Dianthus Therapeutics is a clinical-stage biotechnology company based in New York City and Waltham, Mass. Focused on developing novel monoclonal antibodies with enhanced selectivity and potency, the company aims to create transformative medicines for severe autoimmune and inflammatory diseases. Led by an experienced team of biotech and pharma executives, Dianthus is pioneering next-generation antibody complement therapeutics.
Dianthus Therapeutics is seeking a Director of Clinical Development Scientist to lead the scientific aspects of global Phase III pivotal trials. This role involves ensuring high-quality study design, execution, and interpretation, collaborating with internal and external teams to drive progress of a novel therapeutic asset. The company is a publicly traded, clinical-stage biotech firm focused on monoclonal antibody development for rare autoimmune and inflammatory diseases, operating remotely.
Dianthus Therapeutics is a clinical-stage biotechnology company based in New York City and Waltham, Mass. Focused on developing novel monoclonal antibodies with enhanced selectivity and potency, the company aims to create transformative medicines for severe autoimmune and inflammatory diseases. Led by an experienced team of biotech and pharma executives, Dianthus is pioneering next-generation antibody complement therapeutics.
BioNTech